Check out the companies making headlines midday Monday:
Sysco — Sysco shares rose more than 5 percent and were on track for their best day since Nov.7, 2016. The stock’s surge came after Sysco reported quarterly earnings per share of 75 cents, topping analyst expectations by two cents. The company’s revenue, however, came in slightly below expectations.
Clorox — Clorox reported better-than-expected earnings on Monday, sending its stock up more than 6 percent and on pace for its best day since Sept. 22, 2014. The company also reiterated its 2019 guidance for earnings and revenue.
Alexion Pharmaceuticals — The pharmaceutical company’s stock rose as much as 2.1 percent on the back of better-than-expected quarterly results. Alexion posted earnings per share of $2.14, well above an estimate of $1.82. However, the stock failed to hold its gains and traded 2.5 percent lower.
Allergan — Shares of the drug-maker fell 3.4 percent on Monday after a rival to its famous Botox injection was approved by U.S. regulators. Evolus says its competing wrinkle-fighting injection would be between 20 percent and 25 percent cheaper than the price of Botox. Shares of Evolus jumped last week after the approval.
Sonos — The stock rose nearly 7 percent after Morgan Stanley upgraded it to overweight from equal-weight on the potential upside from its custom home installations and the IKEA partnership. J.P. Morgan also mentioned Sonos would be a good fit for Apple to make strategic acquisitions among Netflix and Activision Blizzard.
Apple — Shares of the tech giant jumped 2.5 percent midday Monday, bringing its year-to-date gains to 8.2 percent. The move higher comes after J.P. Morgan said Apple could acquire a major media player like Netflix.
CME Group — Shares of the derivatives marketplace fell after it reported its average daily volume was down 6 percent from a year earlier.
Roku — Roku shares opened little changed this morning and steadily climbed higher. The stock is now up 11 percent midday, bringing its year-to date gain to a whopping 64 percent. It’s unclear what the fundamental catalyst is for the jump as it’s breaking out from its 200-day moving average.
Match Group – Shares of the dating service slipped 1 percent after Goldman Sachs began coverage with a sell rating. While Goldman said the parent company of Tinder has a “promising” long-term outlook, it thinks Match’s valuation is “high relative to its growth.” Goldman Sachs has a $45 price target on Match’s stock.
—CNBC’s Kate Rooney , Michael Sheetz and Yun Li contributed to this report.